The bright and the dark sides of activin in wound healing and cancer
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Activin was initially described as a protein that stimulates release of follicle stimulating hormone from the pituitary, and it is well known for its important roles in different reproductive functions. In recent years, this multifunctional factor has attracted the attention of researchers in other fields, as new functions of activin in angiogenesis, inflammation, immunity, fibrosis and cancer have been discovered. Studies from our laboratory have identified activin as a crucial regulator of wound healing and skin carcinogenesis. On the one hand, it strongly accelerates the healing process of skin wounds but, on the other hand, it enhances scar formation and the susceptibility to skin tumorigenesis. Finally, results from several laboratories have revealed that activin enhances tumour formation and/or progression in some other organs, in particular through its effect on the tumour microenvironment, and that it also promotes cancer-induced bone disruption and muscle wasting. These findings provide the basis for the use of activin or its downstream targets for the improvement of impaired wound healing, and of activin antagonists for the prevention and treatment of fibrosis and of malignant tumours that overexpress activin. Here, we summarize the previously described roles of activin in wound healing and scar formation and discuss functional studies that revealed different functions of activin in the pathogenesis of cancer. The relevance of these findings for clinical applications will be highlighted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391
Regulation of Wound Healing by Growth Factors and Cytokines
WERNER, S., & GROSE, R. (2003) · Physiological Reviews · doi:10.1152/physrev.2003.83.3.835 · Cited by 3,629
Self-citationInflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis
Coussens, L. M., Raymond, W. W., Bergers, G., Laig-Webster, M., Behrendtsen, O., Werb, Z., Caughey, G. H., & Hanahan, D. (1999) · Genes & Development · doi:10.1101/gad.13.11.1382 · Cited by 946 · cited 1×
“Furthermore, activin induced migration and maturation of mast cells (see glossary in Box 1) (Funaba et al., 2003), and these immune cells can also contribute to malignant progression in skin (Coussens et al., 1999) and pancreatic cancer (Soucek et al., 2007).”
BackgroundThe polarization of immune cells in the tumour environment by TGFβ
Flavell, R. A., Sanjabi, S., Wrzesinski, S. H., & Licona-Limón, P. (2010) · Nature Reviews Immunology · doi:10.1038/nri2808 · Cited by 940 · cited 2×
“Interestingly, the same signalling pathways are also used by TGF-b, explaining some of the overlapping functions of both cytokines, e.g. in the regulation of several immune functions (reviewed by Flavell et al., 2010).”
BackgroundBurgoyne, R. D., & Morgan, A. (2003) · Physiological Reviews · doi:10.1152/physrev.00031.2002 · Cited by 934
Loke, P., Gallagher, I., Nair, M. G., Zang, X., Brombacher, F., Mohrs, M., Allison, J. P., & Allen, J. E. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.3926 · Cited by 274 · cited 1×
“, 2006), a marker for M2 macrophages that are involved in tissue repair processes (Loke et al., 2007) (see glossary in Box 1).”
BackgroundSierra-Filardi, E., Puig-Kröger, A., Blanco, F. J., Nieto, C., Bragado, R., Palomero, M. I., Bernabéu, C., Vega, M. A., & Corbí, A. L. (2011) · Blood · doi:10.1182/blood-2010-09-306993 · Cited by 268
Cited by
Role of EMT in Metastasis and Therapy Resistance
Smith, B., & Bhowmick, N. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5020017 · Cited by 484
Beyond TGFβ: roles of other TGFβ superfamily members in cancer
Wakefield, L. M., & Hill, C. S. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3500 · Cited by 374
Immunoregulation by members of the TGFβ superfamily
Chen, W., & ten Dijke, P. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.112 · Cited by 347
Stem Cell Lineage Infidelity Drives Wound Repair and Cancer
Ge, Y., Gomez, N. C., Adam, R. C., Nikolova, M., Yang, H., Verma, A., Lu, C. P.-J., Polak, L., Yuan, S., Elemento, O., et al. (2017) · Cell · doi:10.1016/j.cell.2017.03.042 · Cited by 343
Neofunction of ACVR1 in fibrodysplasia ossificans progressiva
Hino, K., Ikeya, M., Horigome, K., Matsumoto, Y., Ebise, H., Nishio, M., Sekiguchi, K., Shibata, M., Nagata, S., Matsuda, S., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1510540112 · Cited by 315
Activins and Inhibins: Roles in Development, Physiology, and Disease
Namwanje, M., & Brown, C. W. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a021881 · Cited by 294
Changes in regeneration-responsive enhancers shape regenerative capacities in vertebrates
Wang, W., Hu, C.-K., Zeng, A., Alegre, D., Hu, D., Gotting, K., Ortega Granillo, A., Wang, Y., Robb, S., Schnittker, R., et al. (2020) · Science · doi:10.1126/science.aaz3090 · Cited by 210
“5D), reminiscent of the activation of inhba in human and mouse skin upon injury (26, 30).”
BackgroundResultSignalling by Transforming Growth Factor Beta Isoforms in Wound Healing and Tissue Regeneration
Gilbert, R., Vickaryous, M., & Viloria-Petit, A. (2016) · Journal of Developmental Biology · doi:10.3390/jdb4020021 · Cited by 195
“The specific roles of other members of this superfamily in tissue repair and regeneration have been thoroughly reviewed elsewhere (see [2] and [3] for activins and BMPs, respectively).”
BackgroundHino, K., Horigome, K., Nishio, M., Komura, S., Nagata, S., Zhao, C., Jin, Y., Kawakami, K., Yamada, Y., Ohta, A., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci93521 · Cited by 169
Aykul, S., & Martinez-Hackert, E. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.713487 · Cited by 143
“Several diseases associate with activin A overexpression, including inflammation, fibrosis, and cancer-related muscle wasting (39, 40, 73).”
BackgroundIyer, S., Zhang, S., Yucel, S., Horn, H., Smith, S. G., Reinhardt, F., Hoefsmit, E., Assatova, B., Casado, J., Meinsohn, M.-C., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0818 · Cited by 136
Hongu, T., Pein, M., Insua-Rodríguez, J., Gutjahr, E., Mattavelli, G., Meier, J., Decker, K., Descot, A., Bozza, M., Harbottle, R., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00353-6 · Cited by 118
Mast cells are dispensable for normal and activin‐promoted wound healing and skin carcinogenesis
Antsiferova, M., Martin, C., Huber, M., Feyerabend, T. B., Förster, A., Hartmann, K., Rodewald, H.-R., Hohl, D., & Werner, S. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301350 · Cited by 75
Self-citationMichael, I. P., Saghafinia, S., Tichet, M., Zangger, N., Marinoni, I., Perren, A., & Hanahan, D. (2019) · Developmental Cell · doi:10.1016/j.devcel.2019.04.015 · Cited by 42
KDM6A regulates cell plasticity and pancreatic cancer progression by noncanonical activin pathway
Yi, Z., Wei, S., Jin, L., Jeyarajan, S., Yang, J., Gu, Y., Kim, H. S., Schechter, S., Lu, S., Paulsen, M. T., et al. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.09.014 · Cited by 41
Metadata
- Authors
- Antsiferova, M., & Werner, S.
- Venue
- Journal of Cell Science
- Publisher
- The Company of Biologists
- Published
- 2012-01-01
- Volume
- 125
- Issue
- Pt 17
- Pages
- 3929-37
- ISSN
- 0021-9533 (ISSN-L)
- 1477-9137
- OpenAlex
- W2159824199
- Cited by
- 108
- References
- 7
- FWCI
- 2.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.